⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CASI News
CASI Pharmaceuticals, Inc. Ordinary Shares
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
globenewswire.com
NVS
ALLO
LEGN
CBIO
MBIO
CRSP
INCY
IMPP
SANA
VOR
CARG
AUTL
ARCL
LYEL
PRE
BEAM
CART
TAK
AZN
MRK
BMY
GEN
DGX
GMAB
ABBV
RLGT
CRGO
JNJ
GILD
JAZZ
SYBX
CASI
ATRA
SHEN
BIIB
VREX
G-SHOCK Introduces the GRAVITYMASTER GWRB3000 Series Inspired by Supersonic Flight
prnewswire.com
CASI
Necrotizing Enterocolitis Market to Register Stunning Growth at a CAGR of 26% During the Forecast Period (2026–2036) | DelveInsight
globenewswire.com
JAGX
MRK
CASI
JAZZ
Delisting of Securities from The Nasdaq Stock Market
globenewswire.com
MLGO
EPWK
IVP
SYNX
TWIN
FAT
CASI
TRX
ITRM
IOBT
CASI Pharmaceuticals Receives the Delisting Decision From the Nasdaq Hearings Panel
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Approval of Clinical Trial Application by China NMPA for Phase 1 / 2 Study of CID-103 for Renal Allograft Antibody-Mediated Rejection (AMR)
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia
accessnewswire.com
CASI
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing
accessnewswire.com
CASI
CASI Pharmaceuticals Announces Results from CID-103 Immune Thrombocytopenia Study at the 67th American Society of Hematology (ASH) Annual Meeting
accessnewswire.com
CASI